Gilead Sciences Inc. (GILD) at a glance

Gilead Sciences Inc. (GILD) is a large-cap Healthcare company. It trades at $143.58, with a P/E of 17.1, a 31% profit margin and revenue growth of 4.4%. It pays a 2.6% dividend yield. Vestovix scores it 76/100 overall. Its strongest dimension is Safety (94/100) and its weakest is Income (54/100). It is a relatively defensive holding with below-market volatility.

Price
$143.58
Market cap
$155.93B
P/E ratio
17.1
Dividend yield
2.56%
Beta
0.33
52-week range
$108.46 to $157.29
Vestovix Score76/ 100How this works
Value
83
Growth
75
Income
54
Safety
94
Momentum
66

Other Healthcare stocks

See all